Disease activity and risk of lymphoma in patients with rheumatoid arthritis: Nested case-control study

British Medical Journal

Volumn 317, Issue 7152, 1998, Pages 180-181

  Baecklund, Eva ^a   Ekbom, Anders ^b   Sparén, Pär ^b   Feltelius, Nils ^a   Klareskog, Lars ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT;

ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; LYMPHOMA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR;

EID: 0032543858     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.317.7152.180     Document Type: Article

References (5)

1. Prior P, Symmons DPM, Hawkins CF, Scott DL, Brown R. Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis 1984;43:128-31.
2. Myllykangas-Luosujärvi R, Aho K, Isomäki H. Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol 1995;24:76-8.
3. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
4. Symmons DPM. Neoplasms of the immune system in rheumatoid arthritis. Am J Med 1985;78:22-8.
5. Silman AJ, Petrie J, Hazleman B, Evans SJW. Lymphoproliferative cancer and other malignancy in patients with rheumatoid athritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis 1988;47:988-92.